Enea Pianezzi

ORCID: 0000-0003-3382-4025
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Extracellular vesicles in disease
  • Pluripotent Stem Cells Research
  • Hepatitis Viruses Studies and Epidemiology
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Neuroscience and Neural Engineering
  • Viral Infections and Immunology Research
  • Chemotherapy-related skin toxicity
  • Sleep and related disorders
  • Salmonella and Campylobacter epidemiology
  • Nerve Injury and Rehabilitation
  • Orthopedic Surgery and Rehabilitation
  • Peripheral Neuropathies and Disorders
  • Cardiac electrophysiology and arrhythmias
  • Diet, Metabolism, and Disease
  • Peripheral Nerve Disorders
  • Congenital heart defects research
  • Bacterial biofilms and quorum sensing
  • Chemotherapy-induced cardiotoxicity and mitigation
  • HER2/EGFR in Cancer Research
  • Viral gastroenteritis research and epidemiology
  • Antibiotic Resistance in Bacteria
  • Diet and metabolism studies
  • Antibiotic Use and Resistance

Ente Ospedaliero Cantonale
2021-2024

University of Fribourg
2024

Swiss Institute for Regenerative Medicine
2016-2019

University of Lausanne
2018

University of Zurich
2016

BackgroundCoronavirus-2 (SARS-CoV-2) infection causes an acute respiratory syndrome accompanied by multi-organ damage that implicates a prothrombotic state leading to widespread microvascular clots. The of such coagulation abnormalities are unknown. receptor tissue factor, also known as CD142, is often associated with cell-released extracellular vesicles (EV). In this study, we aimed characterize surface antigens profile circulating EV in COVID-19 patients and their potential implication...

10.1016/j.ebiom.2021.103369 article EN cc-by-nc-nd EBioMedicine 2021-05-01

The occurrence of metallo-beta-lactamase-producing Pseudomonas aeruginosa (MBL-PA) isolates is increasing globally, including in Switzerland. aim this study was to characterise, phenotypically and genotypically, the MBL-PA submitted Swiss National Reference Center for Emerging Antibiotic Resistance (NARA) reference laboratory over a 12-month period from July 2022 2023.

10.1007/s10096-024-04752-8 article EN cc-by European Journal of Clinical Microbiology & Infectious Diseases 2024-01-17

Human-induced pluripotent stem cell (hiPSC)‐derived cardiomyocytes are likely to revolutionize electrophysiological approaches arrhythmias. Recent evidence suggests the somatic origin of hiPSCs may influence their differentiation potential. Owing cardiomyogenic potential, cardiac-stromal progenitor cells (CPCs) an interesting cellular source for generation hiPSC‐derived cardiomyocytes. The effect ionic current blockade in generated from CPCs has not been characterized yet. cell‐derived were...

10.1093/europace/euw352 article EN EP Europace 2016-01-01

Abstract Background and purpose Infections vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type frequency preceding agents is unknown. Methods This was a multicentre, prospective, observational, matched case–control study. NA diagnosed by neuromuscular experts according to validated clinical criteria electrodiagnostic studies. Clinical data biological samples patients were collected within 90 days from disease onset between...

10.1111/ene.16462 article EN cc-by European Journal of Neurology 2024-10-04

After an acute hepatitis E (HEV) outbreak in Southern Switzerland, January 2017 the local public health authorities started active program of food chain control and education. In this retrospective study, we analysed all laboratory-confirmed cases HEV infection diagnosed between 2014 2020. period before intervention, number increased steadily from (4 40 tests, 10%) reaching a peak last quarter 2016 (42 285 14.7 %). Afterwards, positive decreased steadily, its lowest value (0.3%) second 2019....

10.3390/pathogens10020107 article EN cc-by Pathogens 2021-01-22
Coming Soon ...